Inici › Melanoma › Califòrnia › Orange
Assaigs clínics de Melanoma a Orange, CA
14 estudis de Melanoma busquen participants en centres de Orange i voltants (en un radi d'uns 30 milles). Obre un estudi per veure qui hi pot participar i com contactar amb l'equip.
Text oficial de l'estudi (anglès)
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
ReclutantFase 2
- UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
ReclutantFase 3
- St. Joseph Hospital Orange, Orange
- University of California Irvine, UCI Medical Center, Orange
Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma
ReclutantFase 3
- UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
ReclutantFase 1/2
- Children's Hospital of Orange County, Orange
Project: Every Child for Younger Patients With Cancer
ReclutantEstudi observacional
- Children's Hospital of Orange County, Orange
Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid Tumors
ReclutantFase 1 inicial
- Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange
Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial
ReclutantFase 2
- Chao Family Comprehensive Cancer Center, University of California Irvine, Orange
MC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab in Adults With Advanced Melanoma
ReclutantFase 1/2
- University of California Irvine, Orange
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
ReclutantFase 1/2
- UC Irvine/Chao Family Comprehensive Cancer Center, Orange
Neoadjuvant Darovasertib in Primary Uveal Melanoma
ReclutantFase 3
- University of California Irvine Medical Center, Orange
A Study of VET3-TGI in Patients With Solid Tumors
ReclutantFase 1
- UC Irvine Health, Orange
Metronomic Cyclophosphamide With Pembrolizumab in Checkpoint Inhibitor Refractory Melanoma
ReclutantFase 2
- Chao Family Comprehensive Cancer Center University of California, Irvine, Orange
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
ReclutantEstudi observacional
- Massive Bio SYNERGY-AI site, Orange
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Reclutant
- UC Irvine Health - Chao Family Comprehensive Cancer Center, Orange
- UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Orange
Assaigs de Melanoma en altres ciutats
- Houston, TX59 estudis
- New York City, NY38 estudis
- Los Angeles, CA34 estudis
- Nashville, TN33 estudis
- Pittsburgh, PA31 estudis
- Boston, MA26 estudis
- Philadelphia, PA23 estudis
- San Francisco, CA22 estudis
- Durham, NC21 estudis
- Atlanta, GA21 estudis
- St. Louis, MO21 estudis
- Salt Lake City, UT21 estudis
Altres estudis a Orange
- Càncer de pulmó de cèl·lules no petites25 estudis
- Càncer metastàtic20 estudis
- Càncer colorrectal16 estudis
- Càncer d'ovari16 estudis
- Càncer de pàncrees15 estudis
- Càncer de mama14 estudis
- Càncer de pulmó14 estudis
- Càncer de pròstata14 estudis
- Càncer de fetge (carcinoma hepatocel·lular)14 estudis
- Leucèmia mieloide aguda13 estudis
- Càncer (tots els tipus)13 estudis
- Càncer d'estómac13 estudis
De ClinicalTrials.gov, dades recuperades el 5 d’oct. 2026. Cada estudi estableix els seus propis criteris d'elegibilitat; l'equip de l'estudi decideix qui hi pot participar.